h-header

news

News from the world

27

Jan

Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase

  • lobal pharmaceutical output surged in 2025 due to preemptive production ahead of U.S. tariff actions, with a 9.1% increase in manufacturing output.
  • The pharmaceutical sector benefits from structural resilience, stable demand, and strong credit conditions, supporting long-term investment despite economic uncertainties.....[PharmExec]

23

Apr

Top Drugs at Risk of Supply Shortages

Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively...

23

Apr

Regulatory considerations for pharmaceutical excipient selection

The article discusses the role and importance of excipients in medicines, focusing on regulatory aspects...

21

Apr

TGA clarifies therapeutic goods are unaffected by chemical production and import ban

TGA has clarified the impact of Australia’s industrial chemicals standards on medicines, medical...

20

Apr

US FDA Draft Guidance on Establishing Impurity Specifications for Antibiotics

FDA issued the draft guidance for industry, Establishing Impurity Specifications for Antibiotics. This...

slider-banner

h-footer